TY - JOUR
T1 - Plasma dose-response studies with noradrenaline and adrenaline in man.
AU - Clutter, W. E.
AU - Cryer, P. E.
PY - 1980/12/1
Y1 - 1980/12/1
N2 - Graded infusions of noradrenaline (n = 25) and adrenaline (n = 30) were performed in normal human subjects. Plasma noradrenaline thresholds for biologic effects were 1,500-2,000 pg/ml, higher than levels achieved under common physiologic conditions. Thus, noradrenaline functions primarily as a sympathetic postganglionic neurotransmitter although it may also function as a hormone in some physiologic and many pathophysiologic states. Plasma adrenaline thresholds were lower - approximately 100 pg/ml for cardiac chronotropic, systolic pressor and lipolytic effects, 150-200 pg/ml for hyperglycemic, glycolytic, ketogenic and diastolic depressor effects and greater than 400 pg/ml for suppression of insulin secretion. Since these levels lie within the physiologic range, adrenaline is likely to be a biologically important regulatory hormone. Further, noradrenaline and adrenaline were found to accelerate their own plasma metabolic clearance rates.
AB - Graded infusions of noradrenaline (n = 25) and adrenaline (n = 30) were performed in normal human subjects. Plasma noradrenaline thresholds for biologic effects were 1,500-2,000 pg/ml, higher than levels achieved under common physiologic conditions. Thus, noradrenaline functions primarily as a sympathetic postganglionic neurotransmitter although it may also function as a hormone in some physiologic and many pathophysiologic states. Plasma adrenaline thresholds were lower - approximately 100 pg/ml for cardiac chronotropic, systolic pressor and lipolytic effects, 150-200 pg/ml for hyperglycemic, glycolytic, ketogenic and diastolic depressor effects and greater than 400 pg/ml for suppression of insulin secretion. Since these levels lie within the physiologic range, adrenaline is likely to be a biologically important regulatory hormone. Further, noradrenaline and adrenaline were found to accelerate their own plasma metabolic clearance rates.
UR - http://www.scopus.com/inward/record.url?scp=0019289450&partnerID=8YFLogxK
M3 - Article
C2 - 6782584
AN - SCOPUS:0019289450
SN - 0079-6085
VL - 17
SP - 84
EP - 89
JO - Progress in biochemical pharmacology
JF - Progress in biochemical pharmacology
ER -